Related Experiment Video
Updated: Jan 19, 2026
10:21
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
725
PPA1 promotes NSCLC progression via a JNK- and TP53-dependent manner
Dehong Luo1, Daishun Liu1, Wen Shi2
1The Third Affiliated Hospital of Zunyi Medical University/ First People's Hospital of Zunyi, Zunyi, 563200, China.
Oncogenesis
|September 26, 2019
Summary
Inorganic pyrophosphatase (PPA1) drives non-small cell lung cancer (NSCLC) progression by affecting cell apoptosis and proliferation. Its pyrophosphatase activity is crucial for this effect, suggesting PPA1 as a potential therapeutic target for NSCLC.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Inorganic pyrophosphatase (PPA1) is implicated in tumor progression across various cancer types.
- The specific mechanisms by which PPA1 influences lung carcinoma remain largely unelucidated.
- Elevated PPA1 expression is observed in lung carcinoma tissues compared to normal lung tissues.
Purpose of the Study:
- To investigate the role and mechanism of inorganic pyrophosphatase (PPA1) in non-small cell lung cancer (NSCLC) progression.
- To determine if PPA1's enzymatic activity is essential for its pro-tumorigenic effects in NSCLC.
- To identify potential therapeutic targets for NSCLC based on PPA1 function.
Main Methods:
- Quantitative analysis of PPA1 expression in NSCLC tissues and cell lines.
- In vitro experiments involving PPA1 knockdown and ectopic expression in NSCLC cells.
- Assessment of cell apoptosis and proliferation rates following PPA1 manipulation.
- Evaluation of PPA1's effects in conjunction with TP53 expression and JNK pathway modulation.
- Analysis of a catalytically inactive PPA1 mutant (D117A) to assess the role of pyrophosphatase activity.
Main Results:
- PPA1 expression is significantly upregulated in NSCLC tissues and cell lines compared to normal controls.
- PPA1 knockdown inhibits NSCLC cell proliferation and promotes apoptosis.
- Ectopic PPA1 expression enhances NSCLC cell proliferation and reduces apoptosis.
- The pro-tumorigenic effects of PPA1 are dependent on its pyrophosphatase activity, as shown by the D117A mutant.
- PPA1-mediated NSCLC progression involves the TP53 pathway and/or the JNK signaling pathway.
Conclusions:
- PPA1 plays a significant role in promoting NSCLC progression.
- PPA1's pyrophosphatase activity is indispensable for its oncogenic functions in NSCLC.
- PPA1 influences NSCLC progression through mechanisms involving TP53 and JNK signaling.
- PPA1 represents a promising therapeutic target for the treatment of NSCLC.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.6K
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.7K
Related Concept Videos
01:19Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
01:22PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
01:20The JAK-STAT Signaling Pathway
12.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.2K
01:31The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K